Machine Learning

Southeast Asian giant Grab partners with AI travel tech firm Nuitée to launch an in-app hotel booking service, challenging the regional travel industry.

A new partnership integrates 'plug-and-play' smart scales into care platforms, removing tech barriers and empowering proactive disease management.

By automating the production of a groundbreaking immune therapy, a new collaboration could finally unlock the full potential of personalized medicine for cancer.

Shanghai-based Unionfab is expanding its CNC machining to the U.S., Germany, and Canada, challenging established players with aggressive 3-day lead times.

Two Atlanta tech firms unite, combining payment accuracy rules with advanced AI agents to tackle soaring administrative costs and streamline healthcare.

New tools from Checkbox automate intake, update knowledge in real-time, and provide accurate reporting, pushing legal ops toward a more strategic future.

OM1's AI platform analyzed 650,000 patient records, setting a new precedent for using real-world evidence in major regulatory approvals.

Freshly rebranded Keel Infrastructure posts huge Q1 losses, but a $533M war chest and a 2.2GW pipeline show its real focus: the AI data center boom.

A new report says the key to consumer action isn't emotion, but the brain's background 'noise.' This finding could upend the entire advertising industry.

With AI regulations looming, Seekr hires a top marketer to lead the charge in the high-stakes market for auditable and defensible artificial intelligence.

A renewed alliance aims to break key supply chain bottlenecks in gene therapy, offering developers faster access to critical, regulatory-ready materials.

A new drug targeting the root cause of sebum production shows promise in clinical trials, offering hope for millions of moderate to severe acne sufferers.

OneOdio's new Studio Max 2, tuned by DJ KSHMR, claims a record-breaking 9ms latency. Can it finally cut the cord for professional music production?

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

Screendragon's new AI Hub lets marketers build and govern AI agents in their workflows, aiming to solve enterprise issues of control, cost, and compliance.

Quiet Professionals and Spathe Systems merge into Endurion, a new powerhouse aiming to solve data fragmentation for Special Operations with its Pathfinder system.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

With a new CEO known for scaling tech firms, Hivelocity is expanding its bare metal and GPU capacity to capture the booming AI infrastructure market.

As BioPharma races to adopt AI, fragmented data remains a huge hurdle. A Boston forum aims to find solutions for building a trusted digital foundation.

For the 8th straight year, Equashield dominates the CSTD market. We explore the tech, trust, and automation driving its success in protecting workers.